300850997247

The barcode 300850997247 corresponds to SCHERING-PLOUGH/SCHERING LABS 20 S DRIXORAL TABLETS, which contains the active ingredient dextroamphetamine saccharate. Drixoral is primarily used as a stimulant medication for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and may also be prescribed for certain sleep disorders. It is classified as an amphetamine, which stimulates the central nervous system to help increase focus and reduce impulsivity.

Key Details:

• Active Ingredient: Dextroamphetamine saccharate
• Manufacturer: Schering-Plough (now part of Merck & Co.)
• Dosage Form: Tablets for oral administration
• Indications: Treatment of ADHD and certain sleep disorders

Potential Side Effects:

Users of Drixoral may experience a range of side effects, including but not limited to:

• Appetite suppression
• Insomnia
• Increased heart rate and blood pressure
• Anxiety and agitation
• Rarely, psychotic episodes
• Risk of dependence and addiction

Warnings and Precautions:

Drixoral carries a boxed warning indicating the risk of serious mental health issues, such as:

• Depression
• Manic episodes
• Suicidal thoughts

As with all prescription medications, it is critical that Drixoral is used under the supervision of a healthcare provider.

Pricing Information:

In terms of pricing, a bottle of 20 S Drixoral tablets in the United States is estimated to range from $50 to $100 USD. In the UK, the price can vary between £30 to £60 GBP, though these prices may fluctuate based on various factors like location and pharmacy.

Health-related Disclaimer:

Since Drixoral is a prescription medication, it is intended for use under medical supervision. There is no general health-related disclaimer for consumable products concerning this medication since it must be prescribed by a healthcare professional.